Next Article in Journal
Exercise, Diet and Sleeping as Regenerative Medicine Adjuvants: Obesity and Ageing as Illustrations
Previous Article in Journal
Diaphragm Ultrasound in Cardiac Surgery: State of the Art
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Dilemma of Reconstructive Material Choice for Orbital Floor Fracture: A Narrative Review

by
Akash Sivam
1,* and
Natalie Enninghorst
2,3
1
Oral and Maxillofacial Surgery Department, Royal Hobart Hospital, Hobart, TAS 7000, Australia
2
School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia
3
Royal Newcastle Centre, John Hunter Hospital, Newcastle, NSW 2310, Australia
*
Author to whom correspondence should be addressed.
Submission received: 4 December 2021 / Revised: 6 January 2022 / Accepted: 10 January 2022 / Published: 13 January 2022

Abstract

:
The aim of this study is to present a narrative review of the properties of materials currently used for orbital floor reconstruction. Orbital floor fractures, due to their complex anatomy, physiology, and aesthetic concerns, pose complexities regarding management. Since the 1950s, a myriad of materials has been used to reconstruct orbital floor fractures. This narrative review synthesises the findings of literature retrieved from search of PubMed, Web of Science, and Google Scholar databases. This narrative review was conducted of 66 studies on reconstructive materials. Ideal material properties are that they are resorbable, osteoconductive, resistant to infection, minimally reactive, do not induce capsule formation, allow for bony ingrowth, are cheap, and readily available. Autologous implants provide reliable, lifelong, and biocompatible material choices. Allogenic materials pose a threat of catastrophic disease transmission. Newer alloplastic materials have gained popularity. Consideration must be made when deliberating the use of permanent alloplastic materials that are a foreign body with potential body interactions, or the use of resorbable alloplastic materials failing to provide adequate support for orbital contents. It is vital that surgeons have an appropriate knowledge of materials so that they are used appropriately and reduce the risks of complications.

1. Introduction

Orbital floor fractures were first recognised and described in 1844 by MacKenzie and Lang [1]. In 1957, Smith and Regan described orbital fractures as fractures resulting from a sudden increase in hydraulic pressure [2]. This impact is transmitted to periocular structures, resulting in pressure to the orbit that fractures the orbital floor, commonly in the posteromedial region, parallel to the infraorbital nerve where the bone is the thinnest [2,3]. This blow can be directly to the globe or to the inferior orbital rim, causing the floor to buckle [2,4]. Today, orbital fractures are frequently a result of facial trauma by motor vehicle accidents, assault, work and falls and account for 10–25% of facial fractures [5].
Symptoms are commonly periorbital ecchymosis, oedema, enophthalmos, diplopia due to restricted extraocular muscles, infraorbital paraesthesia, blurred vision, and subconjunctival haemorrhage. Less commonly blindness, globe injury, and lacrimal system injury can be identified [6,7,8,9,10]. Despite their frequency treatment is often complicated due to complex anatomy, physiology and aesthetic concerns [11,12]. Even with proper surgical technique, successful anatomical reconstruction and appropriate follow-up complications such as enophthalmos, diplopia resulting from extraocular muscle dysfunction, and infraorbital nerve hypesthesia are frequently seen during long-term follow-up [11,13].
There are three factors that impacts repair or orbital wall fractures, management, timing, and material. The management of orbital blowout fractures has long been controversial and is evolving [13,14]. There have been numerous studies investigating the timing and surgical approach. Current indications to operate are largely based on a defect size of 2 cm2, enophthalmos, entrapment, persistent diplopia, and radiographic evidence of fracture. Traditionally, early aggressive surgical repair, within 14 days, has been recommended and has been shown to be more effective than secondary reconstructive procedures [12,13,14,15]. Within 14 days, there is some resolution of soft tissue oedema that can improve exposure and facilitate dissection [3]. However, evidence of entrapment of extraocular muscles requires urgent reduction of periorbital soft tissues and orbital floor reconstruction [12].
Approaches used to repair orbital floor fractures include transconjunctival, subciliary, mid-lower eyelid, infraorbital, and endoscopic transantral approaches [16]. All these approaches have been proven to allow good exposure and adequate repair of orbital wall fractures. Aside from timing and approach, a third factor for the management of orbital wall fractures are the materials used. Many reconstruction materials for orbital blowout fractures have been described in the literature, including autologous bone transplants (split cranial bone, cartilage, bone fragment, dermal fat, rib), allogenic (human dura matter, lyophilised cartilage, banked bone, fascia lata, heterogenic bovine bone graft) and alloplastic material (silastic tantalum, stainless steel, vitallium, titanium, polymethylmethacrylate, polyvinyl sponge, polyurethane, polyethylene, Teflon, hydroxyapatite, gelfoam, gelfilm, supramid) [3,17]. In the late 19th century, surgical repair of orbital floor fractures were reported using stainless steel wires and antral bone fragments [7,8]. Since the 1950s, reconstruction of the orbital floor using bone substitutes and alloplastic materials has been used [9,10].
Regardless of approach or materials, the goal of treatment remains the same. Unlike other facial fractures, the goal is not typically to achieve bone healing, rather the goal is to reconstruct the defect to the normal anatomical relations of the internal orbit while avoiding complications of the procedure or implant [18].
Surgeons use materials they believe will give the best results with the lowest complication rates. Studies, however, do not consider the fact that the surgeon or surgical centre has developed expertise using a given material; when considering the choice of material, objective analysis regarding the advantages and disadvantages must be considered.
Despite there being a large body of literature that describes the repair of orbital floor fractures using autogenic, allogenic or alloplastic materials, the ideal reconstructive material for orbital floor fractures is unresolved, and remains debated. This can be attributed to a vast majority of studies presenting a comparison between one or two materials in one surgical centre, while often not acknowledging any bias of results due to the experience of surgeons/treatment centres.
There are very few studies that present in one source a comprehensive review and comparison of an exhaustive list of materials’ properties and complications.
This narrative review will analyse the literature regarding the use of materials widely used in orbital floor repair. It will assess the properties, advantages and disadvantages of materials and aim to identify areas of further research.
Therefore, the importance and value of this study is that it will provide surgeons with not only the complication rates of certain materials but the scientific background and understanding of material properties, allowing surgeons to make informed decisions regarding material choice based on scientific evidence.

2. Materials and Methods

2.1. Information Sources

The search was performed on PubMed (Medline), Web of Science and Google Scholar to obtain evidence supporting materials used for orbital floor reconstruction until January 2021. There was no restriction of language. Search keywords including orbital floor/blowout fractures, complications and the various materials used for repair, were used in the search. Eligible studies were also manually scanned to identify additional studies for inclusion. The search was narrowed to studies on scientific, physical and mechanical properties of implant materials and those investigating materials with outcome evaluations following clinical use; however, to expand the number of eligible articles, no filter was used in the search.

2.2. Search Strategy

A broad-based search was implemented using the text words and themes. The keywords were “orbital fracture”, “orbital blowout”, “orbital reconstruction”, “complications”, “autologous bone”, “calvarium”, “calvarial graft”, “autologous cartilage”, “autogenic lyophilized dura”, “titanium mesh”, “medpore”, “porous polyethylene”, “bioactive glass”, “allogenic”, “silicone”, “teflon”, “polyglycolic acid”, “polyglactin” and “polydioxanone”.

2.3. Inclusion Criteria

Inclusion criteria required studies to (1) pertain to orbital floor fractures, (2) evaluate 1 or more biomaterial for orbital floor repair, (3) report immediate and follow-up outcome measures for comparison, and (4) provide a detailed description of scientific and physical properties of biomaterial.

2.4. Exclusion Criteria

Studies related to surgery but not related to orbital floor fracture or orbital floor reconstruction, not relevant to implant materials, and studies that did not provide detailed description of biomaterial were excluded.

2.5. Data Collection and Analysis

Studies were read by the authors and information pertaining to orbital fractures, type of reconstructive materials used, properties of materials, patients and complications were gathered. Analysis was undertaken by thematical analysis of reconstructive material properties, suitability of materials, and complications.

3. Results

3.1. Study Selection

All obtained studies were exported to Endnote software and were verified to remove duplicates. Authors independently screened the search results and identified studies that were potentially relevant based on title and abstract. Relevant studies were read in full and selected according to inclusion criteria. The search conducted in different electronic databases identified 3384 articles. A total of 1549 articles were short-listed after the removal of duplicates. After screening titles and abstracts, 141 studies were assessed for eligibility and 66 studies were included in the narrative review. The detail of the search is presented as PRISMA chart in Figure 1.

3.2. Study Characteristics

This narrative review includes 66 studies on orbital floor fractures. These studies provided data regarding the properties of materials used in orbital floor repair and the advantages and disadvantages of various materials. A total of 39 studies reported the type and number of postoperative complications associated with orbital floor repair and the remaining 27 studies discussed scientific and mechanical properties of materials used in orbital floor reconstruction. In total complications relating to 3870 patients treated for orbital floor repair with various implant materials were reported in the studies. Studies that reported postoperative complications were assigned a level of evidence according to the American Society of Plastic Surgeons Evidence Rating Scale for Therapeutic Studies (Table 1).
Table 2 presents details of 39 studies in terms of level of study, type of study, implant material and follow-up period. A total of 37 (95%) studies were level III studies and 2 (5%) were level IV studies. Of the 39 studies, 9 (23%) were prospective studies, 7 (18%) were retrospective studies and retrospective cohort studies, respectively, 4 (10%) were retrospective reviews, comparative studies, case series, respectively, 2 (5%) were case reports, and 1 (3%) was comprehensive review and follow-up study, respectively.
A number of studies have used more than one type of material, but the studies were predominantly separated into three groups, namely autologous graft materials (14 studies), allogenic graft materials (13 studies), and alloplastic graft materials (12 studies).

3.3. Characteristics of Materials

The goal of orbital wall reconstruction is to restore the normal anatomical relations of the internal orbit. Materials used can be divided into autologous grafts, allogenic materials, porous alloplastic, non-porous alloplastic and resorbable alloplastic materials. The ideal material has physical properties that most closely replicate those of the tissue it replaces [55]. For generic biomaterials, they should be chemically inert, biocompatible, nonallergenic and noncarcinogenic. If alloplastic, it should be cost-effective and capable of sterilization without deterioration of its chemical properties. They should be easily manipulated and adapted in the operating room and retain their form. Materials should allow for fixation to host bone with screws, wire, suture, or adhesive [6,55]; it should not potentiate the growth of microorganisms or resorption of underlying bone or distortion of adjacent structures [56]. The ideal material should be radiopaque for radiographic evaluation [48,50]. It should be easily removed if needed. It should be permanently accepted by the body, or completely resorbed with replacement of host bone [48,50,56,57].
While these characteristics are important, the long-term biocompatibility of materials depends on the relationship between the host and implant. Alloplastic materials may initiate six different biologic reactions: immediate inflammation with early rejection, delayed rejection, fibrous encapsulation, incomplete encapsulation with ongoing cellular reaction, slow resorption, and incorporation [55].
The initial cellular reaction to implanted materials is an acute inflammatory reaction, with polymorphonuclear leukocytes. Lymphocytes and macrophages then migrate to the area and attempt to phagocytise the foreign material. A chronic inflammatory reaction ensues as the material is unable to be phagocytised. Granulation tissue forms and a connective tissue sheath is formed to isolate the implant from the body’s immune response, making the implant well tolerated by the body [58].
The relationship between the body and the implant can be altered by several factors, such as chemical, mechanical, geometric, and physical factors [28,49,59,60]. Before the current implantable alloys, chemical factors would pose problems by corroding implanted metals. These factors have again become of concern in regard to resorbable materials. Resorbable materials undergo breakdown reactions and therefore have the potential to cause a host’s reaction to the breakdown products. Mechanical factors include chronic movement of the implant, discontinuity of the surrounding capsule, and ongoing trauma. These factors can lead to exposure of the implant that will practically never heal over [61]. Geometric and physical factors include size, shape, and physical form that can increase the host response to a certain material [49,59,60]. Porous materials have an increased microscopic adherence of collagen fibrils and capillaries into the pores that allow for decreased capsular contracture and long-term immobility [47]. Small increases in host reaction can affect its longevity. Optimal soft tissue capability is characterised by a limited inflammatory reaction with a thin fibrous encapsulation or mesenchymal ingrowth with minimal macrophage activity [59,62,63]. Therefore, new materials have the goal of incorporating into the host tissue and not isolating from them.

3.4. Autologous Materials

Autologous tissues were the first materials used to reconstruct the orbit and have long been considered the standard treatment for orbital fracture repair [64]. This requires an adequate amount of autologous material (e.g., bone) that is then shaped and inserted to provide rigid structural support to reconstruct the defect. However, they require a second operative donor site, commonly; split calvarial bone, rib, maxillary wall, mandibular symphysis, iliac crest, antral bone or coronoid process. This can increase operative time and morbidity [65,66,67]. The graft can then be placed as onlay grafts, fixed with a plate and screw, fixed with a lag screw or fixed in conjunction with an alloplastic material such as titanium mesh [33,67,68,69,70].

3.4.1. Autologous Bone

The advantage of autologous bone is its inherent strength, rigidity, and vascularisation potential. As the graft material is incorporated as living tissue it does not elicit an immune response against the graft, therefore, demonstrating a relative resistance to infections, extrusion, capsule formation and ocular tethering [65]; however, the use of autologous bone is associated with less favourable outcomes such as limited ability to contour bone, variable graft resorption and donor site morbidity.
Bone is rigid so poses difficulty when contouring and has the propensity to break if moulded beyond its capacity [71]. It has been postulated that the accuracy of reconstruction is better with titanium mesh in comparison to bone grafts [29]. Bone is also of limited quantity and may not be able to be used as the sole material for large defects or fractures involving multiple walls and disruption of the bony buttresses [31,54].
The variable resorption and potential for late-occurring enophthalmos is a major concern regarding bone grafts [55]. Bone resorption occurs to a certain degree over time. Various methods have been identified to reduce the degree of resorption. The literature shows that there is up to 75% resorption for endochondral bone and 20–30% for membranous bone grafts [63,64]. Therefore, membranous bone has been shown to maintain a greater volume of the original graft. Ozaki and Buchman [68] demonstrated that resorption is not due to the embryonic origin of the bone graft, but a result of the microarchitecture. They showed cortical bone is more resistant to resorption than cancellous bone regardless of embryonic origin [68]. An alternative method to decrease resorption is to rigidly fixate the graft under mobile tissue, which promotes ingrowth of the surrounding tissue and vascularisation [72,73].
Another issue with autologous bone grafts relates to harvesting bone from a different donor site. This increases operating time and therefore time under anaesthesia, as well as donor site morbidity [65]. General risks include infection, haematoma, seroma, neurovascular injury, use of drains, increase postoperative recovery time and pain, bony defect and additional scarring. Additionally, certain donor sites are associated with site-specific risks. Rib grafts are associated with pneumothorax and split calvarial bone grafts are associated with dural tears, subarachnoid haemorrhage and intracerebral haematomas [74,75].
Calvarial bone is the preferred choice for autologous bone grafts. It is located in the same operative field, has a high volume of cortical bone, is sufficient for multiple grafts, can be easily used in conjunction with rigid fixation, and is available in sufficient amounts for children [50,70]. Iliac crest and ribs provide large quantities of bone and are relatively easier to contour than cranial bone, however, due to different microarchitectures are prone to greater resorption, have the potential for increased morbidity, and require a second operative site [20,23,38]. Alternative graft sources such as the anterior maxillary wall, ramus, and lingual cortex have been described anecdotally. Their advantages are ease of access and reduced donor site morbidity [43,75]; however, the literature is limited in quantity [76].

3.4.2. Autologous Cartilage

Cartilage from the nasal septum, ribs or ear is commonly used as donor tissue for orbital floor reconstruction [26,39,65]. The benefits include its ease of harvest and contour, adequate strength, reduced donor site morbidity and reduced host immune-related complications. There is also evidence of less resorption at follow-up and the potential for cartilage grafts to calcify over time [26,63,77].
The main sources of cartilage are nasal septum and conchal cartilage [26,39]. Chowdhury and Krause [65] argue that septal cartilage resists warping and that conchal cartilage can be used for small defects and has a natural curvature that fits well in the orbital floor; however, other studies highlight cartilage has the tendency to return to its previous shape unless maintained in shape for several months, which is difficult to accomplish in the internal orbit, and that contouring cartilage will change the intrinsic tensile and extrinsic expansile forces causing a distortion of shape and therefore delayed complications [78]. Patient selection is also important; patients must be free of nasal symptoms, have no previous nasal surgery, no nasal septum deviation or spurs [40]. Autologous cartilage provides unique benefits but due to limited availability, should be used for small defects in select few patients.

3.5. Allogenic Materials

Allogenic materials include allografts, homografts and xenografts. They contain no living cells but possess the osteoinductive and/or osteoconductive properties, and incorporate into the host tissue and provide a structural framework for ingrowth of host tissues. The advantage over autologous grafts is the lack of donor site morbidity, decrease operating time, opportunity to prefabricate the graft and the abundance of supply [55].
Commonly used materials are human dura matter, lyophilized cartilage, banked bone, fascia lata and heterogenic bovine bone graft [51,79]. In two studies, lyophilized dura has demonstrated no infections or extrusion but has been associated with enophthalmos rates of 5.4–20% [30,51]. Demineralised and bovine heterologous bone grafts have been reported in two independent studies to have no graft related complications, incompatibility, inflammation, or infection [79,80].
Despite their positives, two main disadvantages of allogenic grafts exist. First, they have a higher resorption rate in comparison to autologous grafts. Second, the chance of transmission of infectious diseases such as HIV and hepatitis C if grafts are taken from a human donor [65,81,82]. Furthermore, there is a risk of transmission of Creutzfekdt-Jacob disease when grafts are taken from cadaveric dura [83,84].

3.6. Alloplastic Materials

A variety of alloplastic materials have been developed and gained popularity for the reconstruction of the internal orbit due to their ease of use and reduced surgical morbidity. Generally, these materials eliminate the need for a donor site, decrease operative time and are readily available. Disadvantages are that they are a foreign body, can elicit host reaction to the materials, and require removal of the implant if complications arise. The major subgroups are permanent materials such as metallic and non-metallic that confer a lifelong risk of complications and resorbable materials that are immune to late-occurring complications.

3.7. Permanent Alloplastic Materials

3.7.1. Titanium

Titanium is a metallic alloplast that is rigid and malleable, making it an ideal material for reconstructing large defects requiring structural rigidity and strength. Titanium is thin, easy to contour, easily stabilised, maintains its shape, can compensate for volume when contoured without the potential for resorption, can osteointegrate and produce fewer artefacts when visualising on postoperative CT [85,86].
When comparing titanium plates and mesh versus autologous bone grafts, titanium mesh has been shown to provide better overall reconstruction with no significant complications relating to the implant material [29,57]. Sargent and Fulks [87] reviewed 54 patients who underwent repair with Vitallium mesh without bone grafts and reported excellent results with no postoperative infections or need for removal.
Disadvantages include risk of extrusion, infection and damage to soft tissues in repeat trauma. Removal of titanium has been difficult due to fibrous ingrowth and the possibility of osteointegration [86]. Lee and Nunery [41], who reviewed 10 patients repaired with titanium mesh, were presented with orbital adherence syndrome raising concerns of adhesions resulting in ocular muscle restrictions. They found that six presented with cicatricial eyelid retraction and nine with extraocular motility restriction, resulting in diplopia. Of the nine patients with diplopia, all were resolved with removal of the titanium mesh and replacement with 0.4 mm nylon implant.
Rubin and Yaremchuck [48] performed a comprehensive literature review that demonstrated 69 patients treated with titanium mesh reported no complications. However, it was noted that in 4 studies totaling 92 patients, there was an infection rate of 4.4% for metal plates, and 3.3% of implants required removal at follow-up of 6 months to 3 years [48].

3.7.2. Porous Polyethylene

Porous polyethylene, available as Medpore, has been available since 1985; it is a perforated implant material that facilitates ingrowth and therefore reduced the foreign body reactions and capsule formation associated complications. Studies have demonstrated tissue ingrowth and the formation of the mucosal lining. This minimises capsule formation and therefore minimises host’s immune response and implant failure [71].
Romano et al. [47] reviewed 140 patients with facial fractures, 128 of whom had implants placed in the orbit. They reported ease of use, soft tissue ingrowth and no soft tissue adherence complications or extrusion. They found one case of infection resulting in removal of the implant. Similarly, Lupi et al. [44] used porous polyethylene in 32 patients, finding no implant migration, extrusion, or enophthalmos. However, diplopia persisted in 2 patients at 6 months.
Aside from generic disadvantages of alloplasts, porous polyethylene is not radiodense and is difficult to visualise on postoperative CT. Despite this, Wang et al. [52] suggested porous polyethylene and titanium mesh preferable to autologous bone because of decreased operative time and donor site morbidity.

3.7.3. Bioactive Glass

Bioactive glass is a biocompatible material that causes minimal inflammatory response. It is a synthetic material available as blocks or small granules that produces strong chemical bonds, is osteoconductive, and eliminates the need for a donor site [19,35]. In a study of 28 patients with orbital wall fractures, 14 treated with bioactive glass and 14 treated with cartilage, no bioactive glass implants showed implant-related complications. In comparison to the cartilage group that had three cases of diplopia, and two cases of infraorbital nerve paraesthesia [19]. The main advantage is the ease of use, but the material has limited mechanical qualities. It is brittle and rigid and therefore difficult to mold, shape, contour and stabilise as overtightening screws will lead to fracture of the implant; it is therefore rarely used [88].

3.7.4. Silicone

Silicone is cheap, flexible, easy to handle and provides good structural support; however, there are numerous studies that report significant complications even up to 20 years post-operatively. Laboratory studies show that silicone is more prone to fibrous capsule formation and poor incorporation at a cellular level [36,43,46,49,89,90]. Laxenaire et al. [91] studied 137 patients, reporting significant complications and the need for removal of the implant in 13.8% of patients due to infection, implant migration, cutaneous fistulas, dacryocystitis and persistent diplopia. Similarly, Aronowitz et al. [22] found short- and long-term complication rates of 3.9% and 2.8%, respectively. Therefore, despite its favourable characteristics, silicone has been disfavoured due to its complications and the development of other materials.

3.8. Resorbable Alloplastic Materials

3.8.1. Polyglycolic Acid (PGA)

PGA is an implant material that loses its integrity at two months and is 95% resorbed at nine months [92]. Balogh et al. [24] presented 18 patients treated with PGA and found no migration of implants, well-corrected orbital volumes, and one complication of palpebral inflammation that resolved spontaneously. They also commented that the material was easy to use. Hollier et al. [32] used PGA in defects larger than 1 cm2 for 12 patients with a follow-up of six months. One patient developed an inflammatory reaction requiring removal of the implant, and two others developed enophthalmos. They concluded that PGA should not be used for large defects.

3.8.2. Polyglactin

Polyglactin 910 is most commonly known as the suture material Vicryl, it is a resorbable synthetic material composed of lactide and glycolide acids. Vicryl mesh is the most commonly used polyglactin 910 for orbital fractures. Proponents of its use argue that as it is resorbable, layered, so it is easily cut to the appropriate thickness, is soft and pliable, and poses no risk to the tissues of the orbital apex. A study of 28 patients over a 5-year period highlights potential disadvantages of its flimsy nature, requiring up to 56 layers, and low-grade inflammation of the eyelid up to 11 months post-operatively [45].

3.8.3. Polydioxanone

Polydioxanone is a synthetic biodegradable polymer that has been recommended for the repair of orbital defects 1 to 2 cm with communication to the maxillary sinus [34]; however, histological studies show a range of host responses from minimal inflammation to fragmentation and dislocation of the material, causing significant tissue reaction [93].
Iizuka et al. [34] reconstructed defects of 1 to 2 cm in size for 20 patients. They reported the material was well tolerated with no inflammatory complications. They found the most common was inferior migration of the globe, which they recommended overcorrection at time of surgery. Ten patients showed overcorrection, of which nine had transient diplopia that resolved in seven patients at 29 days.
Bauman et al. [25] reconstructed 31 orbits with polydioxanone: One patient required removal of the implant due to haematoma and diplopia; 1 patient required partial removal of the implant due to extrusion; 25 patients had postoperative diplopia with ten having ongoing diplopia 6 months post-operatively. Seven patients developed enophthalmos, of which five had defects greater than 2.5 cm. Similarly, Kontio et al. [37] performed a study on 16 patients and reported enophthalmos in 37% of patients at 36 weeks. They also found one patient developed maxillary sinusitis requiring removal of the implant and a further four patients developing fibrotic sinuses with gas (three) and fluid (one). These authors attributed enophthalmos being a result of weak resultant scarring and recommended polydioxanone not be used for orbital repair.

3.8.4. Poly-L/D-Lactic Acid

Poly-L/D-lactic acid is a bioresorbable plate that leaves a stable shelf of healed bone or soft tissue after complete resorption, providing multiple advantages over permanent implants and serving as useful alternatives to orbital floor reconstruction [42,53]. Multiple studies have identified poly-L/D-lactic acid as a safe material to use for orbital reconstruction with a low complication rate of 3.4% [27,53].
Al-Shukan and Lindqist [20] compared the use of autologous bone and poly-L/D-lactic acid for orbital fractures >2cm2 and found no statistically significant difference in complications with enophthalmos and diplopia, the two most common complications.
Studies investigating long-term clinical and radiological findings have identified no abnormal tissue foreign body reactions in the orbit on MRI [21,27]. Al-Shukan et al. [21] states that poly-L/D-lactic acid shows adequate strength to stabilise bone segments during the critical period of bone healing. Lieger et al. [42] support this claim by finding no evidence of sagging of orbital contents on postoperative CT scans for 46 patients treated with poly-L/D-lactic acid for orbital fractures ≥1.5 cm.
A retrospective study of 94 patients with 98 orbits who had undergone repair with poly-L/D-lactic acid found not only significant improvement in symptoms of ocular mobility, diplopia, enophthalmos and infraorbital hypoesthesia but also complete resorption of biomaterial and formation of neobone on postoperative imaging [53].
It is therefore concluded that poly-L/D-lactic acid is a safe resorbable reconstructive option with a low clinical complication rate that should be considered by surgeons.

3.9. Complications

The type and number of complications reported in the studies is presented in Table 3.
In total, 534 postoperative complications were reported out of 3870 patients who were operated for orbital reconstruction. Most frequent complications include diplopia (22.3%, n = 119), enophthalmos (21.3%, n = 114), removal of implant (13.9%, n = 74), re-operation (10.5%, n = 56), infection (9.2%, n = 49), exposure/extrusion (3.7%, n = 20), restricted EOM (3.6%, n = 19) and proptosis (3.2%, n = 17). All other types of complications accounted for less than 2% of the total complications. Diplopia was associated with 10 out of 16 materials used in orbital reconstruction. Enophthalmos was associated with 12 implant materials.
Complications can be attributed to surgical technique, host response, and toxicity of implant material and there is an overlap between these factors [48,56]. For example, under correction or over correction are related to surgical technique rather than material. Infraorbital nerve paraesthesia and entropian have been associated with surgical technique; however, some materials are easier to use and mould into position and hence might reduce this kind of complications.
It is useful to exclude those complications due to surgical technique and present only those for which implant material plays an important role. Complications related to material include exposure/extrusion, fistula, infection, inflammation, pain, persistent/prolonged oedema, prominence, and removal of the implant due to implant-related complications [48].
Table 4 presents only those complications that are associated with implant material. The figures have limitations due to a small number of patients and should be interpreted with caution. Complications related to implant material are reported in 9 out of 16 implant materials. The highest percentage of complications were associated with silicone (17.5%, n = 93), followed by polyglactin (14.3%, n = 4), autologous bone (unspecified donor site) (11.3%, n = 8), dense polyethylene (5.4%, n = 6), titanium (2.4%, n = 18), Teflon (PTFE) (2.4%, n = 17), Polyglycolic Acid (1.3%, n = 1), and polydioxanone (0.1%, n = 1).

4. Discussion

Treatment of orbital wall fractures is ever-evolving and continues to be a topic of debate. All materials, when used appropriately, produce satisfactory results. However, there is no one material universally successful. The result of this review shows that there are several easily available and user-friendly materials that provide reliable outcomes for the treatment of orbital fractures.
Autologous implants are a lifelong, reliable, biocompatible material that is still considered the gold standard but is associated with donor site morbidity. Use and morbidity often depend on the experience of the surgeon. Allogenic materials are resorbable but consideration of potentially a severe disease transmission must be given. Alloplastic materials are gaining popularity due to their ease of use, availability and reduced surgical morbidity; however, permanent alloplastic materials are associated with risks of a permanent foreign body, while resorbable materials fail to form adequate bone and resultant scarring is too weak to support the orbit’s contents.
The success of material used in orbital floor fractures is determined by various factors, including patient selection, the timing of surgery, execution of sound surgical principles, and the type of implant material used. Selection of implant material is largely dependent upon the surgeon’s preference and the chosen surgical technique. There are currently very few studies exclusively comparing the selection of reconstructive materials for orbital floor fractures. Therefore, further research should prospectively compare commonly used materials while standardising other factors to allow a direct comparison of reconstructive materials. This would help develop guidelines on the selection of implant material for treating orbital fractures.

5. Conclusions

The ideal material is one that is resorbable, osteoconductive, resistant to infection, minimally reactive, does not induce capsule formation, allows for bony ingrowth, cheap, and readily available. This article highlights that an appropriate knowledge of materials is critical and appropriate use as well as patient selection will reduce the risk of complications. In future, it could be helpful conducting a prospective study comparing the most commonly used materials by similar surgical units with surgeons matched to experience. This might highlight superiority of one material over another.

Author Contributions

Conceptualization, A.S. and N.E.; methodology, A.S. and N.E.; formal analysis, A.S.; investigation, A.S.; writing—original draft preparation, A.S.; writing—review and editing, A.S. and N.E.; supervision, N.E. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ng, P.; Chu, C.; Young, N.; Soo, M. Imaging of orbital floor fractures. Australas. Radiol. 1996, 40, 264–268. [Google Scholar] [CrossRef]
  2. Smith, B.; William, F.; Regan, J. Blowout fracture of the orbit: Mechanism and correction of internal orbital fracture. Am. J. Ophthalmol. 1957, 44, 197–205. [Google Scholar]
  3. Gossman, M.D.; Pollock, R.A. Acute Orbital Trauma: Diagnosis and Treatment. In Oculoplastic Surgery; McCord, C.D., Tanenbaum, M., Nunery, W., Eds.; Raven Press: New York, NY, USA, 1995; pp. 515–551. [Google Scholar]
  4. Le Fort, R. Étude expérimentale sur les fractures de la machoire supérieure. Rev. Chir. Paris 1901, 23, 208–227. [Google Scholar]
  5. Brucoli, M.; Arcuri, F.; Cavenaghi, R.; Benech, A. Analysis of complications after surgical repair of orbital fractures. J. Craniofac. Surg. 2011, 22, 1387–1390. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Kirby, E.J.; Turner, J.B.; Davenport, D.L.; Vasconez, H.C. Orbital floor fractures: Outcomes of reconstruction. Ann. Plast. Surg. 2011, 66, 508–512. [Google Scholar] [CrossRef]
  7. Patel, B.C.; Hoffmann, J. Management of complex orbital fractures. Facial Plast. Surg. 1998, 14, 83–104. [Google Scholar] [CrossRef]
  8. McCoy, F. Management of the orbit in facial fractures. Plast. Reconstr. Surg. 1957, 19, 236–245. [Google Scholar] [CrossRef] [PubMed]
  9. Patterson, R.W., Jr.; McCoy, W.J., 3rd; Benedict, W. The Use of Processed Bovine Bone in Orbital Floor Fractures. Arch. Ophthalmol. 1967, 78, 360–364. [Google Scholar] [CrossRef]
  10. Cutright, D.E.; Hunsuck, E.E. The repair of fractures of the orbital floor using biodegradable polylactic acid. Oral Surg. Oral Med. Oral Pathol. 1972, 33, 28–34. [Google Scholar] [CrossRef]
  11. Runci, M.; De Ponte, F.S.; Falzea, R.; Bramanti, E.; Lauritano, F.; Cervino, G.; Famà, F.; Calvo, A.; Crimi, S.; Rapisarda, S.; et al. Facial and Orbital Fractures: A Fifteen Years Retrospective Evaluation of North East Sicily Treated Patients. Open Dent. J. 2017, 11, 546–556. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Burnstine, M.A. Clinical recommendations for repair of orbital facial fractures. Curr. Opin. Ophthalmol. 2003, 14, 236–240. [Google Scholar] [CrossRef] [PubMed]
  13. Levin, L.M.; Kademani, D. Clinical considerations in the management of orbital blow-out fractures. Compend. Contin. Educ. Dent. 1997, 18, 593–602. [Google Scholar]
  14. Dutton, J.J. Management of blow-out fractures of the orbital floor. Surv. Ophthalmol. 1991, 35, 279–280. [Google Scholar] [PubMed]
  15. Scawn, R.L.; Lim, L.H.; Whipple, K.M.; Dolmetsch, A.; Priel, A.; Korn, B.; Kikkawa, D.O. Outcomes of Orbital Blow-Out Fracture Repair Performed Beyond 6 Weeks After Injury. Ophthal. Plast. Reconstr. Surg. 2016, 32, 296–301. [Google Scholar] [CrossRef] [PubMed]
  16. Lee, M.J.; Kang, Y.S.; Yang, J.Y.; Lee, D.Y.; Chung, Y.Y.; Rohrich, R.J. Endoscopic transnasal approach for the treatment of medial orbital blow-out fracture: A technique for controlling the fractured wall with a balloon catheter and Merocel. Plast. Reconstr. Surg. 2002, 110, 417–426. [Google Scholar] [CrossRef]
  17. Holtmann, H.; Eren, H.; Sander, K.; Kübler, N.R.; Handschel, J. Orbital floor fractures—Short- and intermediate-term complications depending on treatment procedures. Head Face Med. 2016, 12, 1–6. [Google Scholar] [CrossRef] [Green Version]
  18. Cole, P.; Boyd, V.; Banerji, S.; Hollier, L.H., Jr. Comprehensive management of orbital fractures. Plast. Reconstr. Surg. 2007, 120, 57s–63s. [Google Scholar] [CrossRef]
  19. Aitasalo, K.; Kinnunen, I.; Palmgren, J.; Varpula, M. Repair of orbital floor fractures with bioactive glass implants. J. Oral Maxillofac. Surg. 2001, 59, 1390–1396. [Google Scholar] [CrossRef]
  20. Al-Sukhun, J.; Lindqvist, C. A comparative study of 2 implants used to repair inferior orbital wall bony defects: Autogenous bone graft versus bioresorbable poly-L/DL-Lactide [P(L/DL)LA 70/30] plate. J. Oral Maxillofac. Surg. 2006, 64, 1038–1048. [Google Scholar] [CrossRef] [PubMed]
  21. Al-Sukhun, J.; Törnwall, J.; Lindqvist, C.; Kontio, R. Bioresorbable poly-L/DL-lactide (P[L/DL]LA 70/30) plates are reliable for repairing large inferior orbital wall bony defects: A pilot study. J. Oral Maxillofac. Surg. 2006, 64, 47–55. [Google Scholar] [CrossRef] [PubMed]
  22. Aronowitz, J.A.; Freeman, B.S.; Spira, M. Long-term stability of Teflon orbital implants. Plast. Reconstr. Surg. 1986, 78, 166–173. [Google Scholar] [CrossRef] [PubMed]
  23. Asamura, S.; Ikada, Y.; Matsunaga, K.; Wada, M.; Isogai, N. Treatment of orbital floor fracture using a periosteum-polymer complex. J. Craniomaxillofac. Surg. 2010, 38, 197–203. [Google Scholar] [CrossRef] [PubMed]
  24. Balogh, C.; Lucas, R.; Kraft, T.; Breton, P.; Freidel, M. Interest of lactic acid polymer implants in the repair of traumatic loss of substance from the orbit floor. Rev. Stomatol. Chir. Maxillofac. 2001, 102, 109–114. (In French) [Google Scholar]
  25. Baumann, A.; Burggasser, G.; Gauss, N.; Ewers, R. Orbital floor reconstruction with an alloplastic resorbable polydioxanone sheet. Int. J. Oral Maxillofac. Surg. 2002, 31, 367–373. [Google Scholar] [CrossRef] [PubMed]
  26. Constantian, M.B. Use of auricular cartilage in orbital floor reconstruction. Plast. Reconstr. Surg. 1982, 69, 951–955. [Google Scholar] [CrossRef]
  27. Cordewener, F.W.; Bos, R.R.; Rozema, F.R.; Houtman, W.A. Poly(L-lactide) implants for repair of human orbital floor defects: Clinical and magnetic resonance imaging evaluation of long-term results. J. Oral Maxillofac. Surg. 1996, 54, 9–13; discussion 13–14. [Google Scholar] [CrossRef]
  28. Düzgün, S.; Kayahan Sirkeci, B. Comparison of post-operative outcomes of graft materials used in reconstruction of blow-out fractures. Turk. J. Trauma Emerg. Surg. 2020, 26, 538–544. [Google Scholar]
  29. Ellis, E., 3rd; Tan, Y. Assessment of internal orbital reconstructions for pure blowout fractures: Cranial bone grafts versus titanium mesh. J. Oral Maxillofac. Surg. 2003, 61, 442–453. [Google Scholar] [CrossRef]
  30. Guerra, M.F.; Pérez, J.S.; Rodriguez-Campo, F.J.; Gías, L.N. Reconstruction of orbital fractures with dehydrated human dura mater. J. Oral Maxillofac. Surg. 2000, 58, 1366–1367. [Google Scholar]
  31. Guo, L.; Tian, W.; Feng, F.; Long, J.; Li, P.; Tang, W. Reconstruction of orbital floor fractures: Comparison of individual prefabricated titanium implants and calvarial bone grafts. Ann. Plast. Surg. 2009, 63, 624–631. [Google Scholar] [CrossRef]
  32. Hollier, L.H.; Rogers, N.; Berzin, E.; Stal, S. Resorbable mesh in the treatment of orbital floor fractures. J. Craniofac. Surg. 2001, 12, 242–246. [Google Scholar] [CrossRef]
  33. Hwang, K.; Kita, Y. Alloplastic template fixation of blow-out fracture. J. Craniofac. Surg. 2002, 13, 510–512. [Google Scholar] [CrossRef]
  34. Iizuka, T.; Mikkonen, P.; Paukku, P.; Lindqvist, C. Reconstruction of orbital floor with polydioxanone plate. Int. J. Oral Maxillofac. Surg. 1991, 20, 83–87. [Google Scholar] [PubMed]
  35. Kinnunen, I.; Aitasalo, K.; Pöllönen, M.; Varpula, M. Reconstruction of orbital floor fractures using bioactive glass. J. Oral Maxillofac. Surg. 2000, 28, 229–234. [Google Scholar] [CrossRef]
  36. Klisovic, D.D.; Katz, S.E.; Lubow, M. The wayward implant: Orbital silicone plate extrusion associated with squamous epithelial downgrowth and infection. Orbit 2002, 21, 149–154. [Google Scholar] [CrossRef] [PubMed]
  37. Kontio, R.; Suuronen, R.; Salonen, O.; Paukku, P.; Konttinen, Y.T.; Lindqvist, C. Effectiveness of operative treatment of internal orbital wall fracture with polydioxanone implant. Int. J. Oral Maxillofac. Surg. 2001, 30, 278–285. [Google Scholar] [CrossRef] [PubMed]
  38. Kontio, R.K.; Laine, P.; Salo, A.; Paukku, P.; Lindqvist, C.; Suuronen, R. Reconstruction of internal orbital wall fracture with iliac crest free bone graft: Clinical, computed tomography, and magnetic resonance imaging follow-up study. Plast. Reconstr. Surg. 2006, 118, 1365–1374. [Google Scholar] [CrossRef]
  39. Kraus, M.; Gatot, A.; Fliss, D.M. Repair of traumatic inferior orbital wall defects with nasoseptal cartilage. J. Oral Maxillofac. Surg. 2001, 59, 1397–1401. [Google Scholar] [CrossRef]
  40. Lai, A.; Gliklich, R.E.; Rubin, P.A. Repair of orbital blow-out fractures with nasoseptal cartilage. Laryngoscope 1998, 108, 645–650. [Google Scholar] [CrossRef]
  41. Lee, H.B.; Nunery, W.R. Orbital adherence syndrome secondary to titanium implant material. Ophthal. Plast. Reconstr. Surg. 2009, 25, 33–36. [Google Scholar] [CrossRef]
  42. Lieger, O.; Schaller, B.; Zix, J.; Kellner, F.; Iizuka, T. Repair of orbital floor fractures using bioresorbable poly-L/DL-lactide plates. Arch. Facial Plast. Surg. 2010, 12, 399–404. [Google Scholar] [CrossRef]
  43. Lipshutz, H.; Ardizone, R.A. Further observations on the use of silicones in the management of orbital fractures. J. Trauma 1965, 5, 617–623. [Google Scholar]
  44. Lupi, E.; Messi, M.; Ascani, G.; Balercia, P. Orbital floor repair using Medpor porous polyethylene implants. Investig. Ophthalmol. Vis. Sci. 2004, 45, 4700. [Google Scholar]
  45. Mauriello, J.A., Jr.; Wasserman, B.; Kraut, R. Use of Vicryl (polyglactin-910) mesh implant for repair of orbital floor fracture causing diplopia: A study of 28 patients over 5 years. Ophthal. Plast. Reconstr. Surg. 1993, 9, 191–195. [Google Scholar] [CrossRef]
  46. Polley, J.W.; Ringler, S.L. The use of Teflon in orbital floor reconstruction following blunt facial trauma: A 20-year experience. Plast. Reconstr. Surg. 1987, 79, 39–43. [Google Scholar]
  47. Romano, J.J.; Iliff, N.T.; Manson, P.N. Use of Medpor porous polyethylene implants in 140 patients with facial fractures. J. Craniofac. Surg. 1993, 4, 142–147. [Google Scholar] [CrossRef] [PubMed]
  48. Rubin, J.P.; Yaremchuk, M.J. Complications and toxicities of implantable biomaterials used in facial reconstructive and aesthetic surgery: A comprehensive review of the literature. Plast. Reconstr. Surg. 1997, 100, 1336–1353. [Google Scholar]
  49. Sewall, S.R.; Pernoud, F.G.; Pernoud, M.J. Late reaction to silicone following reconstruction of an orbital floor fracture. J. Oral Maxillofac. Surg. 1986, 44, 821–825. [Google Scholar] [PubMed]
  50. Sugar, A.W.; Kuriakose, M.; Walshaw, N.D. Titanium mesh in orbital wall reconstruction. Int. J. Oral Maxillofac. Surg. 1992, 21, 140–144. [Google Scholar]
  51. Waite, P.D.; Clanton, J.T. Orbital floor reconstruction with lyophilized dura. J. Oral Maxillofac. Surg. 1988, 46, 727–730. [Google Scholar] [CrossRef]
  52. Wang, S.; Xiao, J.; Liu, L.; Lin, Y.; Li, X.; Tang, W.; Wang, H.; Long, J.; Zheng, X.; Tian, W. Orbital floor reconstruction: A retrospective study of 21 cases. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2008, 106, 324–330. [Google Scholar] [CrossRef]
  53. Young, S.M.; Sundar, G.; Lim, T.C.; Lang, S.S.; Thomas, G.; Amrith, S. Use of bioresorbable implants for orbital fracture reconstruction. Br. J. Ophthalmol. 2017, 101, 1080–1085. [Google Scholar] [CrossRef]
  54. Zunz, E.; Blanc, O.; Leibovitch, I. Traumatic orbital floor fractures: Repair with autogenous bone grafts in a tertiary trauma center. J. Oral Maxillofac. Surg. 2012, 70, 584–592. [Google Scholar] [CrossRef]
  55. Potter, J.K.; Ellis, E. Biomaterials for reconstruction of the internal orbit. J. Oral Maxillofac. Surg. 2004, 62, 1280–1297. [Google Scholar] [CrossRef]
  56. Mok, D.; Lessard, L.; Cordoba, C.; Harris, P.G.; Nikolis, A. A Review of Materials Currently Used in Orbital Floor Reconstruction. Can. J. Plast. Surg. 2004, 12, 134–140. [Google Scholar] [CrossRef] [Green Version]
  57. Rowning, C.W.; Walker, R.V. The use of alloplastics in 45 cases of orbital floor reconstruction. Am. J. Ophthalmol. 1965, 60, 684–699. [Google Scholar]
  58. Coleman, D.L.; King, R.N.; Andrade, J.D. The foreign body reaction: A chronic inflammatory response. J. Biomed. Mater. Res. 1974, 8, 199–211. [Google Scholar] [CrossRef]
  59. Davila, J.C.; Lautsch, E.V.; Palmer, T.E. Some physical factors affecting the acceptance of synthetic materials as tissue implants. Ann. N. Y. Acad. Sci. 1968, 146, 138–147. [Google Scholar] [CrossRef]
  60. Davila, J.C. Prostheses and living tissues. Ann. Thorac. Surg. 1966, 2, 126. [Google Scholar] [CrossRef]
  61. Brown, J.B.; Fryer, M.P. Study and use of synthetic materials such as silicone and Teflon as subcutaneous prostheses. Plast. Reconstr. Surg. 1960, 26, 264. [Google Scholar] [CrossRef]
  62. Calnan, J. The use of inert plastic material in reconstructive surgery. I. A biological test for tissue acceptance. II. Tissue reactions to commonly used materials. Br. J. Plast. Surg. 1963, 16, 1–22. [Google Scholar] [CrossRef]
  63. Vuyk, H.D.; Adamson, P.A. Biomaterials in rhinoplasty. Clin. Otolaryngol. Allied Sci. 1998, 23, 209–217. [Google Scholar] [CrossRef]
  64. Converse, J.M.; Smith, B.; Obear, M.F.; Wood-Smith, D. Orbital blowout fractures: A ten-year survey. Plast. Reconstr. Surg. 1967, 39, 20–36. [Google Scholar] [CrossRef]
  65. Chowdhury, K.; Krause, G.E. Selection of materials for orbital floor reconstruction. Arch. Otolaryngol. Head Neck Surg. 1998, 124, 1398–1401. [Google Scholar] [CrossRef]
  66. Johnson, P.E.; Raftopoulos, I. In situ splitting of a rib graft for reconstruction of the orbital floor. Plast. Reconstr. Surg. 1999, 103, 1709–1711. [Google Scholar] [CrossRef]
  67. Kakibuchi, M.; Fukuda, K.; Yamada, N.; Matsuda, K.; Kawai, K.; Kubo, T.; Sakagami, M. A simple method of harvesting a thin iliac bone graft for reconstruction of the orbital wall. Plast. Reconstr. Surg. 2003, 111, 961–962. [Google Scholar] [CrossRef] [PubMed]
  68. Ozaki, W.; Buchman, S.R. Volume maintenance of onlay bone grafts in the craniofacial skeleton: Micro-architecture versus embryologic origin. Plast. Reconstr. Surg. 1998, 102, 291–299. [Google Scholar] [CrossRef]
  69. Glassman, R.D.; Manson, P.N.; Vanderkolk, C.A.; Iliff, N.T.; Yaremchuk, M.J.; Petty, P.; Defresne, C.R.; Markowitz, B.L. Rigid fixation of internal orbital fractures. Plast. Reconstr. Surg. 1990, 86, 1103–1109; discussion 1110–1111. [Google Scholar] [CrossRef]
  70. Sullivan, P.K.; Rosenstein, D.A.; Holmes, R.E.; Craig, D.; Manson, P.N. Bone-graft reconstruction of the monkey orbital floor with iliac grafts and titanium mesh plates: A histometric study. Plast. Reconstr. Surg. 1993, 91, 776–777. [Google Scholar] [CrossRef]
  71. Gunarajah, D.R.; Samman, N. Biomaterials for repair of orbital floor blowout fractures: A systematic review. J. Oral Maxillofac. Surg. 2013, 71, 550–570. [Google Scholar] [CrossRef]
  72. Lin, K.Y.; Bartlett, S.P.; Yaremchuk, M.J.; Fallon, M.; Grossman, R.F.; Whitaker, L.A. The effect of rigid fixation on the survival of onlay bone grafts: An experimental study. Plast. Reconstr. Surg. 1990, 86, 449–456. [Google Scholar] [CrossRef]
  73. Phillips, J.H.; Rahn, B.A. Fixation effects on membranous and endochondral onlay bone graft revascularization and bone deposition. Plast. Reconstr. Surg. 1990, 85, 891–897. [Google Scholar] [CrossRef] [PubMed]
  74. Young, V.L.; Schuster, R.H.; Harris, L.W. Intracerebral hematoma complicating split calvarial bone-graft harvesting. Plast. Reconstr. Surg. 1990, 86, 763–765. [Google Scholar] [CrossRef]
  75. Ronĉević, R.; Malinger, B. Experience with various procedures in the treatment of orbital floor fractures. J. Oral Maxillofac. Surg. 1981, 9, 81–84. [Google Scholar] [CrossRef]
  76. Goldberg, R.A.; Garbutt, M.; Shorr, N. Oculoplastic uses of cranial bone grafts. Ophthalmic Surg. 1993, 24, 190–196. [Google Scholar] [CrossRef]
  77. Werther, J.R. Not seeing eye-to-eye about septal grafts for orbital fractures. J. Oral Maxillofac. Surg. 1998, 56, 906–907. [Google Scholar] [CrossRef]
  78. Motoki, D.S.; Mulliken, J.B. The healing of bone and cartilage. Clin. Plast. Surg. 1990, 17, 527–544. [Google Scholar] [CrossRef]
  79. Morax, S.; Hurbli, T.; Smida, R. Bovine heterologous bone graft in orbital surgery. Ann. Chir. Plast. Esthétique 1993, 38, 445–450. [Google Scholar]
  80. Neigel, J.M.; Ruzicka, P.O. Use of demineralized bone implants in orbital and craniofacial reconstruction and a review of the literature. Ophthal. Plast. Reconstr. Surg. 1996, 12, 108–120. [Google Scholar] [CrossRef]
  81. Campbell, D.G.; Li, P. Sterilization of HIV with irradiation: Relevance to infected bone allografts. ANZ J. Surg. 1999, 69, 517–521. [Google Scholar] [CrossRef] [PubMed]
  82. Aho, A.J.; Hirn, M.; Aro, H.T.; Heikkilä, J.T.; Meurman, O. Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972–1995. Acta Orthop. Scand. 1998, 69, 559–565. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Nakamura, Y.; Aso, E.; Yanagawa, H. Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurology 1999, 53, 218–220. [Google Scholar] [CrossRef]
  84. Guerra, M.F.M. Human dura mater and Creutzfeldt-Jakob disease. J. Oral Maxillofac. Surg. 2001, 59, 595. [Google Scholar] [CrossRef] [PubMed]
  85. Mackenzie, D.J.; Arora, B.; Hansen, J. Orbital floor repair with titanium mesh screen. J. Craniomaxillofac. Trauma 1999, 5, 9–18. [Google Scholar]
  86. Schubert, W.; Gear, A.J.; Lee, C.; Hilger, P.A.; Haus, E.; Migliori, M.R.; Mann, D.A.; Benjamin, C.I. Incorporation of titanium mesh in orbital and midface reconstruction. Plast. Reconstr. Surg. 2002, 110, 1022–1032. [Google Scholar] [PubMed]
  87. Sargent, L.A.; Fulks, K.D. Reconstruction of internal orbital fractures with Vitallium mesh. Plast. Reconstr. Surg. 1991, 88, 31–38. [Google Scholar] [CrossRef]
  88. Zide, M.F. Late posttraumatic enophthalmos corrected by dense hydroxylapatite blocks. J. Oral Maxillofac. Surg. 1986, 44, 804–806. [Google Scholar] [CrossRef]
  89. Marks, M.W.; Yeatts, R.P. Hemorrhagic cyst of the orbit as a long-term complication of prosthetic orbital floor implant. Plast. Reconstr. Surg. 1994, 93, 856–859. [Google Scholar] [CrossRef]
  90. Jordan, D.R.; St Onge, P.; Anderson, R.L.; Patrinely, J.R.; Nerad, J.A. Complications associated with alloplastic implants used in orbital fracture repair. Ophthalmology 1992, 99, 1600–1608. [Google Scholar] [CrossRef]
  91. Laxenaire, A.; Lévy, J.; Blanchard, P.; Lerondeau, J.C.; Tesnier, F.; Scheffer, P. Complications of silastic implants used in orbital repair. Rev. Stomatol. Chir. Maxillofac. 1997, 98, 96–99. (In French) [Google Scholar]
  92. Hatton, P.V.; Walsh, J.; Brook, I.M. The response of cultured bone cells to resorbable polyglycolic acid and silicone membranes for use in orbital floor fracture repair. Clin. Mater. 1994, 17, 71–80. [Google Scholar] [CrossRef]
  93. de Roche, R.; Adolphs, N.; Kuhn, A.; Gogolewski, S.; Hammer, B.; Rahn, B. Rekonstruktion der Orbita mit Polylaktat-Implantaten: Tierexperimentelle Ergebnisse nach 12 Monaten und klinischer Ausblick. Mund Kiefer Gesichtschir. 2001, 5, 49–56. (In German) [Google Scholar] [CrossRef] [PubMed]
Figure 1. PRISMA flowchart of study selection.
Figure 1. PRISMA flowchart of study selection.
Medicines 09 00006 g001
Table 1. American Society of Plastic Surgeons Level of Evidence Rating Scale for Therapeutic Studies.
Table 1. American Society of Plastic Surgeons Level of Evidence Rating Scale for Therapeutic Studies.
Level of
Evidence
Qualifying Studies
IHigh-quality, multi-centered or single-centered, randomized controlled trial with adequate power; or systematic review of these studies
IILesser-quality, randomized controlled trial; prospective cohort or comparative study; or systematic review of these studies
IIIRetrospective cohort or comparative study; case-control study; or systematic review of these studies
IVCase series with pre/post test; or only post test
VExpert opinion developed via consensus process; case report or clinical example; or evidence based on physiology, bench research or “first principles”
Table 2. List of retrieved studies reported on implant material and postoperative complications.
Table 2. List of retrieved studies reported on implant material and postoperative complications.
AuthorLevel of StudyType of StudyImplant MaterialsFollow-Up
Period
Aitasalo et al. [19]IIIRetrospective reviewBioactive glass1 to 12 months
Al-Sukhun and
Lindqvist [20]
IIIComparative studyAutogenous bone grafts, poly-L/DL-Lactide [P(L/DL)LA 70/30]2–36 weeks
Al-Sukhun et al. [21]IIIRetrospective cohort studyPoly-L/DL-Lactide [P(L/DL)LA 70/30]-
Aronowitz et al. [22]IIIRetrospective studyTeflon (PTFE)Mean, 16 years
Asamura et al. [23]IIIRetrospective cohort studyIlium and periosteum polymer complex2–22 months
Balogh et al. [24]IIIRetrospective cohort studyPolyglycolic acid (PGA)24 to 43 months
Baumann et al. [25]IIIFollow-up studyPolydioxanone6 months
Brucoli et al. [5]IIIRetrospective cohort studyAutologous calvarial bone, titanium mesh, tutopatch sheetMean, 39 months
Constantian [26]IVCase seriesAutogenous tissues7 months to 3.5 years
Cordewener et al. [27]IIIRetrospective cohort studyPoly-D-Lactic Acid-
Düzgün and Sirkeci [28]IIIComparative studyCartilage, bone grafts, titanium mesh, porous polyethylene implantMean, 14 months
Ellis and Tan [29]IIIRetrospective reviewCranial bone grafts, titanium mesh-
Guerra et al. [30]IIIRetrospective studyAllogenic lyophilized dura3 months to 1 year
Guo et al. [31]IIIComparative studyCalvaria bone graft, titanium mesh>2 weeks
Hollier et al. [32]IIIRetrospective cohort studyPolyglycolic Acid (PGA)Upto 12 months
Holtmann et al. [17]IIIRetrospective studyTitanium mesh-
Hwang and Kita [33]IIIProspective studyTitanium mesh-
Iizuka et al. [34]IIIProspective studyPolydioxanone9 to 45 months
Kinnunen et al. [35]IIIComparative studyAutogenous ear cartilage, bioactive glass2 to 5 years
Kirby et al. [6]IIIRetrospective cohort studyAutologous bone, Titanium, porous polyethyleneMean, 38.8 weeks
Klisovic et al. [36]IVCase reportSilicone18 months
Kontio et al. [37]IIIProspective studyPolydioxanoneMean, 29 weeks
Kontio et al. [38]IIIProspective studyIliac bone graftMean, 7.8 months
Kraus et al. [39]IIIProspective studyAutogenous septal cartilage1 week to 6 months
Lai, A. [40]IIIProspective studyNasal septal cartilage3 months to 4 years
Lee and Nunery [41]IIIRetrospective reviewTitanium mesh and titanium plate5 to 18 months
Lieger et al. [42]IIIRetrospective studyPoly-L/DL-Lactide [P(L/DL)LA 70/30] 3 to 12 months
Lipshutz and Ardizone [43]IVCase seriesSilicone-
Lupi et al. [44]IIIRetrospective studyPorous polyethylene-
Mauriello et al. [45]IIICase seriesPolyglactin1 to 24 months
Polley and Ringler [46]IIIRetrospective studyTeflon (PTFE)3 months to 15 years
Romano et al. [47]IIIProspective studyPorous polyethylene-
Rubin and Yaremchuk [48]IIIComprehensive reviewPorous polyethylene, dense polyethylene, silicone, tefflon (PTFE)-
Sewall et al. [49]IVCase reportSilicone-
Sugar et al. [50]IIIProspective studyTitanium meshMean, 24 months
Waite and Clanton [51]IIIProspective studyLyophilized dura12 months
Wang et al. [52]IIIRetrospective studyAutogenous bone, titanium mesh, Medpor1 to 6 months
Young et al. [53]IIIRetrospective reviewPoly-L/DL-lactide (P[L/DL]LA) 85/15, (P[L/DL]LA) 70/30, Polycaprolactone15 to 24 months
Zunz et al. [54]IVCase seriesCalvarial, iliac autogenous bone graftsMean, 12.5 months
- Not reported.
Table 3. Reconstruction materials and postoperative complications.
Table 3. Reconstruction materials and postoperative complications.
Implant MaterialAuthorPatientsComplicationsTotal
Complications
Autologous Calvarial BoneBrucoli et al. [5]
Guo et al. [31]
Ellis and Tan [29]
Zunz et al. [54]
87Diplopia (7)
Enophthalmos (10)
17
Autologous Iliac BoneDüzgün and Sirkeci [28]
Zunz et al. [54]
Asamura et al. [23]
Al-Sukhun and Lindqvist [20]
Kontio et al. [38]
72Diplopia (15)
Haematoma donor site (2)
Enophthalmos (4)
Infraorbital nerve paraesthesia (2)
Orbital dystopia (7)
30
Autologous Bone (unspecified donor site)Kirby et al. [6]71Re-operation (17)
Removal (4)
Diplopia (10)
Enophthalmos (16)
Restricted EOM (2)
Infection (4)
Proptosis (4)
57
Autologous Conchal Ear CartilageConstantian [26]
Kinnunen et al. [35]
Düzgün and Sirkeci [28]
33Diplopia (8)
Enophthalmos (2)
Infraorbital nerve paraesthesia (2)
12
Autologous Nasal Septal CartilageKraus et al. [39]
Lai et al. [40]
33Enophthalmos (1)
Infraorbital nerve paraesthesia (2)
Lower lid oedema (1)
4
Allogenic Lyophilized DuraWaite and Clanton [51]
Guerra et al. [30]
70Enophthalmos (3)
Infraorbital paraesthesia (4)
Cicatricial problems (2)
9
TitaniumBrucoli et al. [5]
Kirby et al. [6]
Holtman et al. [17]
Sugar et al. [50]
Hwang and Kita [33]
Ellis and Tan [29]
Lee and Nunery [41]
Düzgün and Sirkeci [28]
741Re-operation (16)
Removal (10)
Diplopia (14)
Enophthalmos (12)
Restricted EOM (15)
Infection (8)
Proptosis (5)
80
Porous PolyethyleneKirby et al. [6]
Rubin and Yaremchuk [48]
Romano et al. [47]
Hwang and Kita [33]
Düzgün and Sirkeci [28]
Lupi et al. [44]
326Re-operation (23)
Removal (7)
Diplopia (9)
Enophthalmos (13)
Restricted EOM (2)
Infection (7)
Proptosis (8)
Overcorrection (1)
Undercorrection (1)
Implant extrusion (2)
73
Dense PolyethyleneRubin and Yaremchuk [48]78Removal (1)
Infection (2)
Oedema (3)
6
Bioactive GlassKinnunen et al. [35]
Aitasalo et al. [19]
50Diplopia (5)
Infraorbital nerve dysfunction (6)
Entropion (1)
Removal (1)
13
SiliconeRubin and Yaremchuk [48]
Sewall et al. [49]
Hwang and Kita [33]
Lipshutz and Ardizone [43]
Klisovic et al. [36]
530Infection (25)
Exposure/extrusion (16)
Persistent oedema (2)
Prominence (2)
Pain (6)
Removal (42)
93
Teflon (PTFE)Rubin and Yaremchuk [48]
Polley and Ringler [46]
Aronowitz et al. [22]
702Diplopia (11)
Enophthalmos (15)
Infection (3)
Exposure/extrusion (4)
Removal (9)
Fistula (1)
43
Polyglycolic Acid (PGA)Balogh et al. [24]
Hollier et al. [32]
78Enophthalmos (2)
Inflammatory reaction (1)
Inflammation (1)
4
PolyglactinMauriello et al. [45]28Inflammation (4)4
PolydioxanoneHoltman et al. [17]
Kontio et al. [37]
Iizuka et al. [34]
Baumann et al. [25]
774Diplopia (38)
Exophthalmos (10)
Enophthalmos (29)
Prolonged oedema (1)
78
Poly-D-Lactic AcidCordewener et al. [27]
Al-Sukhun et al. [21]
Al-Sukhun and Lindqvist [20]
Leiger et al. [42]
Young et al. [53]
176Diplopia (1)
Exophthalmos (5)
6
Unspecified ImplantsWang et al. [52]21Diplopia (1)
Enophthalmos (2)
Infraorbital numbness (2)
5
Table 4. Postoperative complications attributed to implant material.
Table 4. Postoperative complications attributed to implant material.
Implant MaterialTotal Number of PatientsComplications Rates (%)
Exposure/ExtrusionFistulaInfectionInflammationPainPersistent/Prolonged OedemaProminenceRemoval of ImplantOverall
Autologous Calvarial Bone87000000000
Autologous Iliac Bone72000000000
Autologous Bone (unspecified donor site)71005.600005.611.3
Autologous Conchal Ear Cartilage33000000000
Autologous Nasal Septal Cartilage33000000000
Allogenic Lyophilized Dura70000000000
Titanium741001.100001.32.4
Porous Polyethylene3260.702.300002.35.4
Dense Polyethylene78002.6003.801.37.7
Bioactive Glass5000000002.02.0
Silicone5303.004.701.10.40.47.917.5
Teflon (PTFE)7020.60.10.400001.32.4
Polyglycolic Acid (PGA)780001.300001.3
Polyglactin2800014.3000014.3
Polydioxanone774000000.1000.1
Poly-D-Lactic Acid176000000000
Unspecified Implants21000000000
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sivam, A.; Enninghorst, N. The Dilemma of Reconstructive Material Choice for Orbital Floor Fracture: A Narrative Review. Medicines 2022, 9, 6. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines9010006

AMA Style

Sivam A, Enninghorst N. The Dilemma of Reconstructive Material Choice for Orbital Floor Fracture: A Narrative Review. Medicines. 2022; 9(1):6. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines9010006

Chicago/Turabian Style

Sivam, Akash, and Natalie Enninghorst. 2022. "The Dilemma of Reconstructive Material Choice for Orbital Floor Fracture: A Narrative Review" Medicines 9, no. 1: 6. https://0-doi-org.brum.beds.ac.uk/10.3390/medicines9010006

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop